CHAPTER I

SCOPE
Article 1
1
This Regulation applies to genetically modified organisms, hereinafter ‘GMOs’, authorised for placing on the market in accordance with Regulation 1829/2003 of the European Parliament and of the Council or—
a
in England, the Genetically Modified Organisms (Deliberate Release) Regulations 2002,
b
in Wales, the Genetically Modified Organisms (Deliberate Release) (Wales) Regulations 2002,
c
in Scotland, the Genetically Modified Organisms (Deliberate Release) (Scotland) Regulations 2002,
and applications for placing on the market under such legislation.
2
This Regulation does not apply to medicinal products for human and veterinary use authorised under—
a
Regulation
(EC) No 726/2004
of the European Parliament and of the Council,
b
the Human Medicines Regulations 2012, or
c
the Veterinary Medicines Regulations 2013,
or applications for authorisation under such legislation.
Art. 1 substituted (31.12.2020) by The Genetically Modified Organisms (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/90), regs. 1(2)(b), 6(2) (as amended by S.I. 2019/759, regs. 1(a), 12(3) and S.I. 2020/1421, reg. 1(4), Sch. paras. 4(2), 5(2)); 2020 c. 1, Sch. 5 para. 1(1)